Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Fluorescence Imaging Using Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

NCT07146295 is registered in ClinicalTrials.gov with Isabelle Henskens as lead sponsor.

NCT NCT07146295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07146295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Fluorescence Imaging Using Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer
Lead sponsor
Isabelle Henskens
Phase
Not applicable
Overall status
Recruiting
Start date
April 18, 2025
Completion date
August 31, 2026
Enrollment
1,760 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, fluorescence imaging, indocyanine green (icg), lymph node mapping, lymphatic metastasis, radioisotopes, sentinel lymph node, sentinel lymph node biopsy (slnb), sentinel lymph node detection